Attached files
| file | filename |
|---|---|
| 10-K/A - AMENDMENT NO.1 TO FORM 10-K - Sage Therapeutics, Inc. | d892363d10ka.htm |
| EX-31.1 - EX-31.1 - Sage Therapeutics, Inc. | d892363dex311.htm |
| EX-31.2 - EX-31.2 - Sage Therapeutics, Inc. | d892363dex312.htm |
Exhibit 32.1
CERTIFICATIONS UNDER SECTION 906
Pursuant to section 906 of the Sarbanes-Oxley Act of 2002 (subsections (a) and (b) of section 1350, chapter 63 of title 18, United States Code), each of the undersigned officers of Sage Therapeutics, Inc., a Delaware corporation (the “Company”), does hereby certify, to such officer’s knowledge, that:
The Annual Report for the year ended December 31, 2014 (the “Form 10-K/A”) of the Company fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, and the information contained in the Form 10-K/A fairly presents, in all material respects, the financial condition and results of operations of the Company.
| Dated: March 16, 2015 | /s/ Jeffrey M. Jonas | |||||
| Jeffrey M. Jonas, M.D. | ||||||
| Chief Executive Officer, President and Director | ||||||
| (Principal Executive Officer) | ||||||
| Dated: March 16, 2015 | /s/ Kimi Iguchi | |||||
| Kimi Iguchi | ||||||
| Chief Financial Officer and Secretary | ||||||
| (Principal Financial Officer) | ||||||